| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.2M | +32.6% |
| Cost of Revenue | $11.1M | +57.4% |
| Gross Profit | $3.1M | -15.1% |
| R&D Expense | $128K | -3.0% |
| SG&A Expense | $3.2M | +4.7% |
| Operating Income | -$3.4M | -23.8% |
| Pre-tax Income | -$3.0M | -5.5% |
| Income Tax | -$285K | — |
| Net Income | -$2.7M | +4.6% |
| EPS (Basic) | -$0.17 | +10.5% |
| EPS (Diluted) | -$0.17 | +10.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $2.0M | +136.1% |
| Inventory | $1.7M | +11.0% |
| Current Assets | $4.2M | +55.3% |
| Total Assets | $12.8M | +286.7% |
| Current Liabilities | $11.0M | +321.6% |
| Long-term Debt | $766K | +243.5% |
| Total Liabilities | $11.5M | +319.7% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.7M | +25.3% |
| Capital Expenditures | $123K | +132.1% |
| Investing Cash Flow | -$1.3M | -2439.6% |
| Financing Cash Flow | $3.1M | +395.5% |
| Free Cash Flow | -$1.8M | +21.6% |
| $1.3M |
| +130.1% |